Summit Trail Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$561K Sell
3,238
-1,740
-35% -$357K 0.01% 1131
2025
Q4
$1.28M Sell
4,978
-4,055
-45% -$1.06M 0.02% 671
2025
Q3
$2.36M Buy
9,033
+1,306
+17% +$343K 0.03% 361
2025
Q2
$1.89M Buy
+7,727
New +$1.93M 0.03% 281
2024
Q4
Sell
-1,289
Closed -$410K 546
2024
Q3
$410K Sell
1,289
-160
-11% -$57K 0.01% 450
2024
Q2
$543K Buy
1,449
+367
+34% +$124K 0.01% 358
2024
Q1
$376K Buy
1,082
+50
+5% +$18.9K 0.01% 406
2023
Q4
$473K Sell
1,032
-8
-0.8% -$3.94K 0.02% 295
2023
Q3
$507K Buy
1,040
+308
+42% +$145K 0.02% 268
2023
Q2
$328K Buy
732
+53
+8% +$26.7K 0.01% 354
2023
Q1
$330K Buy
+679
New +$336K 0.01% 299
2018
Q1
Sell
-745
Closed -$206K 993
2017
Q4
$206K Buy
+745
New +$184K 0.03% 418

Other funds holding HUM

Summit Trail Advisors's HUM Position: Q1 2026 in Review

Summit Trail Advisors reduced its Humana (HUM) stake by 35% in Q1 2026, selling an estimated $357K and leaving 3,238 shares worth $561K. The position accounts for 0.01% of the portfolio, ranked #1131.

Summit Trail Advisors first reported a position in HUM in Q4 2017 and has held it in 12 quarters since. The position peaked at $2.36M in Q3 2025. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Summit Trail Advisors held 3,238 shares of Humana worth $561K as of Q1 2026.
  • Summit Trail Advisors sold 1,740 Humana shares in Q1 2026, an estimated $357K.
  • Humana made up 0.01% of Summit Trail Advisors's portfolio in Q1 2026, its #1131 holding.
  • Summit Trail Advisors first reported a position in Humana in Q4 2017 and has held it in 12 quarters since.
  • Summit Trail Advisors's Humana position peaked at $2.36M in Q3 2025.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.